NeuroMetrix Inc. (NURO)

1.33
NASDAQ : Health Technology
Prev Close 1.34
Day Low/High 1.29 / 1.37
52 Wk Low/High 1.20 / 3.09
Avg Volume 202.50K
Exchange NASDAQ
Shares Outstanding 7.36M
Market Cap 9.86M
EPS -11.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Technology

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix, Inc. (NASDAQ: NURO) today closed a $3.

NeuroMetrix Reports Q3 2017 Financial Results

NeuroMetrix Reports Q3 2017 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30, 2017.

NeuroMetrix, Inc. Announces Date For 2017 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2017 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter financial results before the opening of the market on Thursday October 19, 2017.

NeuroMetrix Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12th, 2017

NeuroMetrix Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12th, 2017

NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 19 th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.

Two Studies Derived From Quell Health Cloud To Be Presented At Upcoming PAINWeek National Conference

Two Studies Derived From Quell Health Cloud To Be Presented At Upcoming PAINWeek National Conference

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the upcoming PAINWeek national conference to be held in Las Vegas, NV, September 5-9.

NeuroMetrix Teams Up With U.S. Pain Foundation To Raise Awareness Of Chronic Pain

NeuroMetrix Teams Up With U.S. Pain Foundation To Raise Awareness Of Chronic Pain

In recognition of Pain Awareness Month this September, NeuroMetrix, Inc.

NeuroMetrix Announces Issuance Of New U.S. Patent For Automated Control Of Quell Therapy During Sleep

NeuroMetrix Announces Issuance Of New U.S. Patent For Automated Control Of Quell Therapy During Sleep

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix Announces DPNCheck Distribution Agreement With Fukuda Denshi In Japan

NeuroMetrix Announces DPNCheck Distribution Agreement With Fukuda Denshi In Japan

NeuroMetrix, Inc. (Nasdaq: NURO) today reported an agreement with Fukuda Denshi for DPNCheck ® distribution in Japan.

NeuroMetrix Announces Shipment Of 100,000th Quell Device Since Launch In 2015

NeuroMetrix Announces Shipment Of 100,000th Quell Device Since Launch In 2015

NeuroMetrix, Inc. (Nasdaq: NURO) reported today that it had shipped its 100,000 th Quell ® wearable device for treatment of chronic pain since commercial launch in mid-2015.

NeuroMetrix Reports Q2 2017 Financial Results

NeuroMetrix Reports Q2 2017 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended June 30, 2017.

NeuroMetrix, Inc. Announces Date For 2017 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. Announces Date For 2017 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 second quarter financial results before the opening of the market on Thursday July 20, 2017.

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock

NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock

NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a private placement of 7,000...

NeuroMetrix Reports Promotion Of Michael MacDonald To Senior Vice President And General Manager Of Diagnostics

NeuroMetrix Reports Promotion Of Michael MacDonald To Senior Vice President And General Manager Of Diagnostics

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and General Manager of Diagnostics.

NeuroMetrix Provides Update On Quell Health Cloud Including Promotion Of Dr. Xuan Kong To Chief Data Scientist

NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its data science initiative and the related Quell ® Health Cloud.

NeuroMetrix Provides Update On Quell Wearable Pain Relief Clinical Program

NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell ® clinical program.

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix To Present At The Marcum Microcap Conference On June 16, 2017

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N.

NeuroMetrix Exhibits Quell Wearable Technology At 31st Annual SLEEP Meeting

NeuroMetrix, Inc. (Nasdaq: NURO) is showing  Quell®, its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017, the 31st Annual...

NeuroMetrix To Present At The LD Micro Invitational Conference On June 6, 2017

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N.

NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.

NeuroMetrix Wins SBANE New England Innovation Award

NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ®...

NeuroMetrix Launches The LivingQuell Blog, A New Platform For Exploring Perspectives On Chronic Pain

NeuroMetrix, Inc. (Nasdaq: NURO) today announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain - as well as the rapidly growing user base of the company's...

TheStreet Quant Rating: E+ (Sell)